Ignite Creation Date:
2024-05-05 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 9:40 AM
Study NCT ID:
NCT00590785
Status:
COMPLETED
Last Update Posted:
2017-08-25
First Post:
2007-12-26
Brief Title:
Phase III Comparison of Adjuvant Chemotherapy WHigh-Dose Cyclophosphamide Plus Doxorubicin AC vs Sequential Doxorubicin Fol by Cyclophosphamide A-C in High Risk Breast Cancer Patients With 0-3 Positive Nodes Intergroup CALGB 9394
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
96-041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cancer and Leukemia Group B | NETWORK |